Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Lonafarnib|DRUG: Placebo|DRUG: anastrozole
Sponsor: Merck Sharp & Dohme LLC